Mark J. Nuell, Ph.D.

Dr. Mark Nuell is a registered patent attorney and is presently of counsel to Ditthavong, Steiner & Mlotkowski, a full-service law firm engaged in obtaining, commercializing and defending intellectual property.

Dr. Nuell has been working in the field of intellectual property since 1991 and is an active member of the California and Virginia bars. Dr. Nuell works principally in the life science and chemical arts.

Dr. Nuell assists clients, including start-up and small companies as well as Fortune 500 companies, in the planning of their intellectual property strategy and in the obtaining of patent rights in their inventions, including management of their patent portfolios. His technical specialties span the arts of chemistry and the life sciences including novel chemical compounds and formulations of them, genetic engineering materials and methods, cloned nucleic acids, vectors, vaccines, gene therapies, cell lines, recombinant proteins, and antibodies. In addition, Dr. Nuell works in the fields of materials science, polymer compositions, diagnostic and therapeutic compositions and methods, separation materials and methods, various analytic methods, and petrochemical processes and apparatus.

Dr. Nuell’s practice also includes a variety of transactional, due diligence and opinion work, including patentability, validity and infringement analyses and freedom to operate opinions, relating to commercialization of intellectual property.

AREAS OF PRACTICE

• Life sciences

• Chemical patent practice

EDUCATION

• J.D., George Mason University School of Law (with honors)

• Ph.D., University of Illinois

• B.S., University of Michigan (cum laude)

BAR & COURT ADMISSIONS

• California Bar (2010)

• Virginia Bar (1997)

• U.S. Patent and Trademark Office (1993)

BIBLIOGRAPHY

“Basics of Patents: Are You Protected? Fundamentals of US Patents and Inventorship”, National Academy of Continuing Legal Education - April 2022.

“Legal Issues Relating to Artificial Intelligence and Inventions”, National Academy of Continuing Legal Education - April 2021.

Nuell, M.J., “Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.”, pp. 135-142 in Top 20 Food and Drug Cases, 2012, and Cases to Watch, 2013, J. B. Reiss and G. J. Wartman, eds., © 2013 by FDLI, Washington, D.C.

Nuell, M.J., “How Big Is Your Boat? The ‘Experimental Use’ Safe Harbour”, World Intellectual Property Review, pp. 62-64, Nov. – Dec. 1012.

Nuell, M.J. and Bobel, A., “Prometheus Laboratories, Inc. v. Mayo Collaborative Services”, pp. 197-208 in­ Top 20 Food and Drug Cases, 2011 & Cases to Watch, 2012, J.B. Reiss and G.J. Wartman, eds., © 2012 by FDLI, Washington, D.C.

Nuell, M.J. and Chen, D.P., “Bilski v. Kappos”, pp. 247-254 in ­Top 20 Food and Drug Cases, 2010 & Cases to Watch, 2011, J.B. Reiss, ed., © 2011 by FDLI, Washington, D.C.

Nuell, M.J. and Hess Eliason, M., “The Clones War”, Food and Drug Law Journal 66:47-72 (2011).

Nuell, M.J. (Nov. 5, 2010), “The Clones War: Chapter Two - Myriad Files Their Brief on Appeal”, PLI Practice Center.

Nuell et al., U.S. Patent 5,658,792, issued August 19, 1997.

McClung, J.K., King, R.L., Walker, L.S., Danner, D.B., Nuell, M.J., Stewart, D.A. and Dell’Orco,R.T. (1992), “Expression of Prohibitin, an Antiproliferative Protein”, Experimental Gerontology 27:413-417.

White, J.J., Ledbetter, D.B., Eddy, R.L. Jr, Shows, T., Stewart, D.A., Nuell, M.J., Friedman, V., Wood, C.A., Owens, G.A., McClung, J.K., Danner, D.B. and Morton, C. (1991), “Assignment of the Human Prohibitin Gene to Chromosome 17”, Genomics 11:228-230.

Nuell M.J., Stewart, D.A., Walker, L., Friedman, V., Wood, C.M., Owens, G., Smith, J.R., Schneider, E.L., Dell’Orco, R.T., Lumpkin, C.K., Danner, D.B. and McClung, J.K. (1991), “Prohibitin, An Evolutionarily Conserved, Intracellular Protein that Blocks DNA Synthesis in Normal Fibroblasts and HeLa Cells”, Molecular and Cellular Biology 11:1372-1381.

McClung J.K., Danner, D.B., Stewart, D.A., Smith, J.R., Schneider, E.L., Lumpkin, C.K., Dell’Orco, R.T. and Nuell, M.J. (1989),“Isolation of a cDNA Clone That Hybrid Selects Antiproliferative Activity from Rat Liver”, Biochemical and Biophysical Research Communications 164:1316-1322.

Nuell, M.J., McClung, J.K., Danner, D.B. and Smith, J.R. (1989),“Approaches to Cloning an Antiproliferative Gene from Rat Liver”, Experimental Gerontology 24:469-476.

Nuell, M.J., Fang, G.-H., Axley, M.J., Kenigsberg, P. and Hager, L.P. (1988),“Isolation and Nucleotide Sequence of the Chloroperoxidase Gene from Caldariomyces fumago", Journal of Bacteriology 170:1007-1011.

Fang, G.-H., Axley, M.J., Kenigsberg, P., Nuell, M.J. and Hager, L.P. (1986), "Cloning and Sequencing of Chloroperoxidase CDNA”, Nucleic Acids Research 14:8061-8071.

Olsen, G.J., Pace, N.R., Nuell, M.J., Kaine, B.P., Gupta, R. and Woese, C.R. (1985),“Sequence of the 16S rRNA gene from the Thermoacidophilic Archaebacterium Sulfolobus sulfataricus and its Evolutionary Implications”, Journal of Molecular Evolution 22:301-307.

CONTACT

Email: mnuell@dcpatent.com